Your browser doesn't support javascript.
loading
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events.
Sakuma, Masashi; Iimuro, Satoshi; Shinozaki, Tomohiro; Kimura, Takeshi; Nakagawa, Yoshihisa; Ozaki, Yukio; Iwata, Hiroshi; Miyauchi, Katsumi; Daida, Hiroyuki; Suwa, Satoru; Sakuma, Ichiro; Nishihata, Yosuke; Saito, Yasushi; Ogawa, Hisao; Matsuzaki, Masunori; Ohashi, Yasuo; Taguchi, Isao; Toyoda, Shigeru; Inoue, Teruo; Nagai, Ryozo.
Afiliação
  • Sakuma M; Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
  • Iimuro S; Innovation and Research Support Center, International University of Health and Welfare, Tokyo, Japan.
  • Shinozaki T; Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nakagawa Y; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
  • Ozaki Y; Department of Cardiology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
  • Iwata H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Miyauchi K; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Daida H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Suwa S; Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
  • Sakuma I; Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan.
  • Nishihata Y; Department of Cardiovascular Medicine, St. Lukes International Hospital, Tokyo, Japan.
  • Saito Y; Chiba University, Chiba, Japan.
  • Ogawa H; Kumamoto University, Kumamoto, Japan.
  • Matsuzaki M; St. Hill Hospital, Ube, Japan.
  • Ohashi Y; Department of Integrated Science and Technology for Sustainable Society, Chuo University, Tokyo, Japan.
  • Taguchi I; Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
  • Toyoda S; Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
  • Inoue T; Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan. inouet@dokkyomed.ac.jp.
  • Nagai R; Japan Red Cross Society, Nasu Red Cross Hospital, Otawara, Japan. inouet@dokkyomed.ac.jp.
BMC Med ; 20(1): 441, 2022 11 14.
Article em En | MEDLINE | ID: mdl-36372869
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores de Hidroximetilglutaril-CoA Redutases / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores de Hidroximetilglutaril-CoA Redutases / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão